Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:38 pm Purchase | 2024-11-19 | 13G | Sigyn Therapeutics, Inc. SIGY | Brio Capital Master Fund Ltd. | 158,932 9.990% | 36,828 (+30.16%) | Filing History |
| 2024-02-08 12:48 pm Purchase | 2024-01-09 | 13G | Sigyn Therapeutics, Inc. SIGY | Brio Capital Master Fund Ltd. | 122,104 9.990% | 122,104 (New Position) | Filing History |
| 2022-02-04 10:47 am Purchase | 2022-01-27 | 13G | Sigyn Therapeutics, Inc. SIGY | Brio Capital Master Fund Ltd. | 93,146 9.990% | 7,766 (+9.10%) | Filing History |
| 2021-01-27 12:35 pm Purchase | 2021-01-17 | 13G | Sigyn Therapeutics, Inc. SIGY | Brio Capital Master Fund Ltd. | 85,380 9.990% | 85,380 (New Position) | Filing History |
| 2021-01-14 3:49 pm Unchanged | 2020-12-31 | 13G | Sigyn Therapeutics, Inc. SIGY | Alpha Capital Anstalt | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-10-29 2:41 pm Purchase | 2020-10-19 | 13G | Sigyn Therapeutics, Inc. SIGY | Osher Capital Partners LLC | 85,380 9.990% | 85,380 (New Position) | Filing History |